IFPMA Code of Practice 2019 – Key Changes
The IFPMA Code of Practice is a living document and has been revised five times over recent decades, ensuring that practices in the biopharmaceutical industry are governed by ethical standards in line with societal expectations.
The new IFPMA Code of Practice will come into effect on 1st January 2019.This video and supporting slide-deck summarizes the key changes between the new IFPMA Code of Practice 2019 and its 2012 predecessor, and discusses certain implications of these revisions for our members.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.Learn more
Media ContactAbigail Jones email@example.com